• Tiago Biachi de Castria
  • José Mauricio Mota


Many attempts have been made to classify gastric cancer in order to predict natural history, prognosis, and treatment responses of gastric cancer patients. However, only a few of them have been definitively embraced by physicians in their everyday decision-making process. Although some heterogeneity between classifications, criteria based on microscopic morphologic features have stood the test of time due to their simplicity and meaningful differences in molecular features and clinical outcomes among groups.


Gastric cancer Diffuse Signet-ring cell Histology Classification 


  1. 1.
    Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.CrossRefPubMedGoogle Scholar
  2. 2.
    Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gan. 1968;59:251–8.PubMedGoogle Scholar
  3. 3.
    Ming SC. Gastric carcinoma. A pathobiological classification. Cancer. 1977;39:2475–85.CrossRefPubMedGoogle Scholar
  4. 4.
    Edge S, Byrd D, Compton C. AJCC (American Joint Committee on Cancer) cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  5. 5.
    Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med. 2004;128:765–70.PubMedGoogle Scholar
  6. 6.
    Correa P, Sasano N, Stemmermann GN, Haenszel W. Pathology of gastric carcinoma in Japanese populations: comparisons between Miyagi prefecture, Japan, and Hawaii. J Natl Cancer Inst. 1973;51:1449–59.CrossRefPubMedGoogle Scholar
  7. 7.
    Piazuelo MB, Correa P. Gastric cancer: overview. Colomb Medica (Cali, Colomb). 2013;44:192–201.Google Scholar
  8. 8.
    Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267:105–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Chen Y-C, Fang W-L, Wang R-F, Liu C-A, Yang M-H, Lo S-S, et al. Clinicopathological variation of Lauren classification in gastric cancer. Pathol Oncol Res. 2016;22:197–202.CrossRefPubMedGoogle Scholar
  10. 10.
    Qiu M, Cai M, Zhang D, Wang Z, Wang D, Li Y, et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med. 2013;11:58.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Stiekema J, Cats A, Kuijpers A, van Coevorden F, Boot H, Jansen EPM, et al. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? Eur J Surg Oncol. 2013;39:686–93.CrossRefPubMedGoogle Scholar
  12. 12.
    Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am. 2013;42:261–84.CrossRefPubMedGoogle Scholar
  13. 13.
    Palestro G, Pellicano R, Fronda GR, Valente G, De Giuli M, Soldati T, et al. Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy. World J Gastroenterol. 2005;11:7131–5.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Il PD, Yun JW, Park JH, Oh SJ, Kim HJ, Cho YK, et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci. 2006;51:1371–9.CrossRefGoogle Scholar
  15. 15.
    Almeida R, Almeida J, Shoshkes M, Mendes N, Mesquita P, Silva E, et al. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. J Pathol. 2005;207:396–401.CrossRefPubMedGoogle Scholar
  16. 16.
    Kim H, An JY, Noh SH, Shin SK, Lee YC, Kim H. High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol. 2011;26:585–92.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Tiago Biachi de Castria
    • 1
  • José Mauricio Mota
    • 1
  1. 1.Instituto do Câncer do Estado de São PauloSão PauloBrazil

Personalised recommendations